loadpatents
name:-0.08666205406189
name:-0.082596778869629
name:-0.014468193054199
Murphy; Brian R. Patent Filings

Murphy; Brian R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Murphy; Brian R..The latest application filed is for "development of dengue virus vaccine components".

Company Profile
13.85.76
  • Murphy; Brian R. - Bethesda MD
  • Murphy; Brian R. - Beijing CN
  • MURPHY; Brian R. - Golden CO
  • Murphy, Brian R - Bethesda MD
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Development Of Dengue Virus Vaccine Components
App 20220251521 - Whitehead; Stephen S. ;   et al.
2022-08-11
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus
Grant 11,400,150 - Pletnev , et al. August 2, 2
2022-08-02
Development of dengue virus vaccine components
Grant 11,332,722 - Whitehead , et al. May 17, 2
2022-05-17
Attenuated mutant dengue viruses comprising a mutation in the NS5 non-structural protein
Grant 11,318,196 - Whitehead , et al. May 3, 2
2022-05-03
Genetically Stable Live Attenuated Respiratory Syncytial Virus Vaccine And Its Production
App 20210330782 - Collins; Peter L. ;   et al.
2021-10-28
Genetically stable live attenuated respiratory syncytial virus vaccine and its production
Grant 10,980,872 - Collins , et al. April 20, 2
2021-04-20
Construction Of West Nile Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused By West Nile Virus
App 20210069317 - Pletnev; Alexander G. ;   et al.
2021-03-11
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus
Grant 10,869,920 - Pletnev , et al. December 22, 2
2020-12-22
Dengue Tetravalent Vaccine Containing A Common 30 Nucleotide Deletion In The 3'-utr Of Dengue Types 1,2,3, And 4, Or Antigenic Chimeric Dengue Viruses 1,2,3, And 4
App 20200392469 - Whitehead; Stephen S. ;   et al.
2020-12-17
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4
Grant 10,837,003 - Whitehead , et al. November 17, 2
2020-11-17
Development Of Dengue Virus Vaccine Components
App 20200318083 - Whitehead; Stephen S. ;   et al.
2020-10-08
Development of dengue virus vaccine components
Grant 10,724,007 - Whitehead , et al.
2020-07-28
Live Attenuated Virus Vaccines For La Crosse Virus And Other Bunyaviridae
App 20200147202 - Whitehead; Stephen S. ;   et al.
2020-05-14
Development Of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses
App 20200085939 - Whitehead; Stephen S. ;   et al.
2020-03-19
Live attenuated virus vaccines for La Crosse virus and other bunyaviridae
Grant 10,561,724 - Whitehead , et al. Feb
2020-02-18
Construction Of West Nile Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused By West Nile
App 20200030435 - Pletnev; Alexander G. ;   et al.
2020-01-30
Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
Grant 10,500,264 - Whitehead , et al. Dec
2019-12-10
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus
Grant 10,456,461 - Pletnev , et al. Oc
2019-10-29
Genetically Stable Live Attenuated Respiratory Syncytial Virus Vaccine And Its Production
App 20190282690 - Collins; Peter L. ;   et al.
2019-09-19
Genetically stable live attenuated respiratory syncytial virus vaccine and its production
Grant 10,307,476 - Collins , et al.
2019-06-04
Development Of Dengue Virus Vaccine Components
App 20190119654 - Whitehead; Stephen S. ;   et al.
2019-04-25
Live Attenuated Virus Vaccines For La Crosse Virus And Other Bunyaviridae
App 20190117762 - Whitehead; Stephen S. ;   et al.
2019-04-25
Live attenuated virus vaccines for la crosse virus and other bunyaviridae
Grant 10,206,995 - Whitehead , et al. Feb
2019-02-19
Construction Of West Nile Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused By West Nile Virus
App 20180369358 - Pletnev; Alexander G. ;   et al.
2018-12-27
Development of dengue virus vaccine components
Grant 10,160,957 - Whitehead , et al. Dec
2018-12-25
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus
Grant 10,058,602 - Pletnev , et al. August 28, 2
2018-08-28
Development Of Dengue Virus Vaccine Components
App 20180171308 - Whitehead; Stephen S. ;   et al.
2018-06-21
Live Attenuated Virus Vaccines For La Crosse Virus And Other Bunyaviridae
App 20180104326 - Whitehead; Stephen S. ;   et al.
2018-04-19
Live attenuated virus vaccines for la crosse virus and other bunyaviridae
Grant 9,884,104 - Whitehead , et al. February 6, 2
2018-02-06
Dengue Tetravalent Vaccine Containing A Common 30 Nucleotide Deletion In The 3'-utr Of Dengue Types 1, 2, 3, And 4, Or Antigenic Chimeric Dengue Viruses 1, 2, 3, And 4
App 20180010099 - Whitehead; Stephen S. ;   et al.
2018-01-11
Development Of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses
App 20180008693 - Whitehead; Stephen S. ;   et al.
2018-01-11
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
Grant RE46,641 - Whitehead , et al. December 19, 2
2017-12-19
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
Grant RE46,631 - Whitehead , et al. December 12, 2
2017-12-12
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4
Grant 9,783,787 - Whitehead , et al. October 10, 2
2017-10-10
Attenuated mutant dengue viruses comprising a mutation in the NS4B non-structural protein
Grant 9,707,287 - Whitehead , et al. July 18, 2
2017-07-18
Genetically Stable Live Attenuated Respiratory Syncytial Virus Vaccine And Its Production
App 20170189520 - Collins; Peter L. ;   et al.
2017-07-06
Genetically stable live attenuated respiratory syncytial virus vaccine and its production
Grant 9,624,475 - Collins , et al. April 18, 2
2017-04-18
Apparatus,system And Method Of Geofencing
App 20170034656 - Wang; Zhi Gang ;   et al.
2017-02-02
Live Attenuated Virus Vaccines For La Crosse Virus And Other Bunyaviridae
App 20160367657 - Whitehead; Stephen S. ;   et al.
2016-12-22
Development of dengue virus vaccine components
Grant RE46,042 - Whitehead , et al. June 28, 2
2016-06-28
Live attenuated virus vaccines for La Crosse virus and other Bunyaviridae
Grant 9,255,252 - Whitehead , et al. February 9, 2
2016-02-09
Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses
Grant 9,238,799 - Pletnev , et al. January 19, 2
2016-01-19
Development of dengue virus vaccine components
Grant 9,090,873 - Whitehead , et al. July 28, 2
2015-07-28
Attenuated human parainfluenza virus, methods and uses thereof
Grant 9,034,343 - Skiadopoulos , et al. May 19, 2
2015-05-19
Genetically Stable Live Attenuated Respiratory Syncytial Virus Vaccine And Its Production
App 20150118732 - Collins; Peter L. ;   et al.
2015-04-30
Development Of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses
App 20150064214 - Whitehead; Stephen S. ;   et al.
2015-03-05
Detection of boilerplate content
Grant 8,898,296 - Zeng , et al. November 25, 2
2014-11-25
Construction Of West Nile Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused By West Nile Virus
App 20140294892 - Pletnev; Alexander G. ;   et al.
2014-10-02
Recombinant attenuated dengue viruses comprising a deletion in the 3' untranslated region and additional attenuating mutations induced by chemical mutagenesis
Grant RE45,123 - Whitehead , et al. September 9, 2
2014-09-09
Attenuated dengue virus comprising mutations in the NS3 gene
Grant RE45,053 - Whitehead , et al. July 29, 2
2014-07-29
Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
Grant RE45,016 - Whitehead , et al. July 15, 2
2014-07-15
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus
Grant 8,778,671 - Pletnev , et al. July 15, 2
2014-07-15
Live Attenuated Virus Vaccines For La Crosse Virus And Other Bunyaviridae
App 20140023679 - Whitehead; Stephen S. ;   et al.
2014-01-23
Recombinant attenuated dengue viruses comprising mutations in NS5 and the 3' untranslated region
Grant 8,632,782 - Whitehead , et al. January 21, 2
2014-01-21
Antigenic Chimeric Tick-borne Encephalitis Virus/dengue Virus Type 4 Recombinant Viruses
App 20140004147 - Pletnev; Alexander G. ;   et al.
2014-01-02
Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses
Grant 8,568,739 - Pletnev , et al. October 29, 2
2013-10-29
Development Of Dengue Virus Vaccine Components
App 20130089567 - Whitehead; Stephen S. ;   et al.
2013-04-11
Recovery of recombinant human parainfluenza virus type 2 (HYPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens
Grant 8,367,074 - Skiadopoulos , et al. February 5, 2
2013-02-05
Recovery Of Recombinant Human Parainfluenza Virus Type 2 (hypiv2) From Cdna And Use Of Recombinant Hpiv2 In Immunogenic Compositions And As Vectors To Elicit Immune Responses Against Piv And Other Human Pathogens
App 20130023030 - SKIADOPOULOS; Mario H. ;   et al.
2013-01-24
Dengue Tetravalent Vaccine Containing A Common 30 Nucleotide Deletion In The 3'-utr Of Dengue Types 1, 2, 3, And 4, Or Antigenic Chimeric Dengue Viruses 1, 2, 3, And 4
App 20130011433 - Whitehead; Stephen S. ;   et al.
2013-01-10
Development of dengue virus vaccine components
Grant 8,337,860 - Whitehead , et al. December 25, 2
2012-12-25
Detection Of Boilerplate Content
App 20120297025 - Zeng; Jian ;   et al.
2012-11-22
Live attenuated virus vaccines for La Crosse virus and other Bunyaviridae
Grant 8,298,541 - Whitehead , et al. October 30, 2
2012-10-30
Neutralizing monoclonal antibodies to respiratory syncytial virus
Grant 8,221,759 - Pilkington , et al. July 17, 2
2012-07-17
Development Of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses
App 20120114694 - Whitehead; Stephen S. ;   et al.
2012-05-10
Hexavalent bovine rotavirus reassortant composition designed for use in developing countries
Grant 8,168,202 - Kapikian , et al. May 1, 2
2012-05-01
Neutralizing Monoclonal Antibodies To Respiratory Syncytial Virus
App 20120087909 - Pilkington; Glenn R. ;   et al.
2012-04-12
Antigenic Chimeric Tick-borne Encephalitis Virus/dengue Virus Type 4 Recombinant Viruses
App 20120076821 - Pletnev; Alexander G. ;   et al.
2012-03-29
Production Of Attenuated Negative Stranded Rna Virus Vaccines From Cloned Nucleotide Sequences
App 20120064569 - Murphy; Brian R. ;   et al.
2012-03-15
System And Method For Modifying An Article And A Modified Article
App 20110308610 - MURPHY; Brian R.
2011-12-22
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4
Grant 8,075,903 - Whitehead , et al. December 13, 2
2011-12-13
Recombinant attenuated dengue viruses comprising a deletion in the 3' untranslated region and additional attenuating mutations induced by chemical mutagenesis
Grant 8,039,003 - Whitehead , et al. October 18, 2
2011-10-18
Live Attenuated Virus Vaccines For La Crosse Virus And Other Bunyaviridae
App 20110200630 - Whitehead; Stephen S. ;   et al.
2011-08-18
RECOMBINANT HUMAN PARAINFLUENZA TYPE 1 VIRUSES (HPIV1s) CONTAINING MUTATIONS IN OR DELETION OF THE C PROTEIN ARE ATTENUATED IN AFRICAN GREEN MONKEYS AND IN CILIATED HUMAN AIRWAY EPITHELIAL CELLS AND ARE POTENTIAL VACCINE CANDIDATES FOR HPIV1
App 20110189232 - Bartlett; Emmalene ;   et al.
2011-08-04
Recovery Of Recombinant Human Parainfluenza Virus Type 2 (hypiv2) From Cdna And Use Of Recombinant Hpiv2 In Immunogenic Compositions And As Vectors To Elicit Immune Responses Against Piv And Other Human Pathogens
App 20110143422 - SKIADOPOULOS; Mario H. ;   et al.
2011-06-16
Attenuated parainfluenza virus (PIV) vaccines
Grant 7,951,383 - Murphy , et al. May 31, 2
2011-05-31
Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from CDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens
Grant 7,919,301 - Skiadopoulos , et al. April 5, 2
2011-04-05
Human Parainfluenza Viruses Having Separated P And C Genes
App 20100330120 - Collins; Peter L. ;   et al.
2010-12-30
Chimeric Sle/dengue Type 4 Antigenic Viruses
App 20100316670 - Blaney; Joseph E. ;   et al.
2010-12-16
Attenuated chimeric respiratory syncytial virus
Grant 7,846,455 - Collins , et al. December 7, 2
2010-12-07
Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines
Grant 7,842,798 - Buchholz , et al. November 30, 2
2010-11-30
Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines
Grant 7,829,102 - Buchholz , et al. November 9, 2
2010-11-09
Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens
Grant 7,820,181 - Skiadopoulos , et al. October 26, 2
2010-10-26
Production of attenuated, human-bovine chimeric respiratory syncytial viruses for use in immunogenic compositions
Grant 7,820,182 - Buchholz , et al. October 26, 2
2010-10-26
Safe code-motion of dangerous instructions during compiler optimization
Grant 7,810,086 - Murphy , et al. October 5, 2
2010-10-05
Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes
Grant 7,744,902 - Krempl , et al. June 29, 2
2010-06-29
Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
Grant 7,709,007 - Murphy , et al. May 4, 2
2010-05-04
Development Of Dengue Virus Vaccine Components
App 20100104598 - Whitehead; Stephen S. ;   et al.
2010-04-29
Recombinant human metapneumovirus and its use
Grant 7,704,491 - Collins , et al. April 27, 2
2010-04-27
Recovery of recombinant human parainfluenza virus type 1 (HPIV1) from cDNA and use of recombinant HPIV1 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens
Grant 7,704,509 - Murphy , et al. April 27, 2
2010-04-27
Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes
Grant 7,662,397 - Krempl , et al. February 16, 2
2010-02-16
Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
Grant 7,632,508 - Schmidt , et al. December 15, 2
2009-12-15
Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
Grant 7,622,123 - Skiadopoulos , et al. November 24, 2
2009-11-24
Development Of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses
App 20090263424 - Whitehead; Stephen S. ;   et al.
2009-10-22
Dengue Tetravalent Vaccine Containing A Common 30 Nucleotide Deletion In The 3' -utr Of Dengue Types 1, 2, 3, And 4 Or Antigenic Chimeric Dengue Viruses 1, 2, 3, And 4
App 20090258036 - Whitehead; Stephen S. ;   et al.
2009-10-15
Attenuated dengue virus comprising mutations in the NS3 gene
Grant 7,560,118 - Whitehead , et al. July 14, 2
2009-07-14
Neutralizing monoclonal antibodies to respiratory syncytial virus
App 20090110684 - Pilkington; Glenn R. ;   et al.
2009-04-30
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
Grant 7,517,531 - Whitehead , et al. April 14, 2
2009-04-14
Production Of Attenuated Negative Stranded Rna Virus Vaccines From Cloned Nucleotide Sequences
App 20090081728 - Murphy; Brian R. ;   et al.
2009-03-26
Neutralizing monoclonal antibodies to respiratory syncytial virus
Grant 7,488,477 - Pilkington , et al. February 10, 2
2009-02-10
Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2
Grant 7,485,440 - Collins , et al. February 3, 2
2009-02-03
Polynucleotides encoding recombinant respiratory syncytial viruses expressing immune modulatory molecules
Grant 7,465,794 - Collins , et al. December 16, 2
2008-12-16
Hexavalent Bovine Rotavirus Reassortant Composition Designed for Use in Developing Countries
App 20080292660 - Kapikian; Albert Z. ;   et al.
2008-11-27
RECOVERY OF RECOMBINANT HUMAN PARAINFLUENZA VIRUS TYPE 2 (HPIV2) FROM cDNA AND USE OF RECOMBINANT HPIV2 IN IMMUNOGENIC COMPOSITIONS AND AS VECTORS TO ELICIT IMMUNE RESPONSES AGAINST PIV AND OTHER HUMAN PATHOGENS
App 20080286848 - SKIADOPOULOS; Mario H. ;   et al.
2008-11-20
Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2
App 20080138861 - Collins; Peter L. ;   et al.
2008-06-12
Human neutralizing monoclonal antibodies to respiratory syncytial virus
Grant 7,364,737 - Burton , et al. April 29, 2
2008-04-29
Attenuated parainfluenza virus (PIV) vaccines
App 20080096264 - Murphy; Brian R. ;   et al.
2008-04-24
Use of recombinant live-attenuated parainfluenza virus (PIV) as a vector to protect against disease caused by PIV and respiratory syncytial virus (RSV)
Grant 7,314,631 - Murphy , et al. January 1, 2
2008-01-01
Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines
App 20070184069 - Buchholz; Ursula ;   et al.
2007-08-09
Construction and use of recombinant parainfluenza viruses expressing a chimeric glycoprotein
Grant 7,250,171 - Tao , et al. July 31, 2
2007-07-31
Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
App 20070134271 - Skiadopoulos; Mario H. ;   et al.
2007-06-14
Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
Grant 7,226,602 - Whitehead , et al. June 5, 2
2007-06-05
Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
App 20070092534 - Whitehead; Stephen S. ;   et al.
2007-04-26
Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences
Grant 7,208,161 - Murphy , et al. April 24, 2
2007-04-24
Attenuated human-bovine chimeric parainfluenza virus(PIV) vaccines
Grant 7,201,907 - Schmidt , et al. April 10, 2
2007-04-10
Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens
Grant 7,192,593 - Murphy , et al. March 20, 2
2007-03-20
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
App 20070009552 - Whitehead; Stephen S. ;   et al.
2007-01-11
Safety verification of computer program
App 20070006197 - Murphy; Brian R. ;   et al.
2007-01-04
Safe code-motion of dangerous instructions during compiler optimization
App 20070006187 - Murphy; Brian R. ;   et al.
2007-01-04
Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
App 20060159703 - Murphy; Brian R. ;   et al.
2006-07-20
Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
App 20060099226 - Schmidt; Alexander C. ;   et al.
2006-05-11
Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines
App 20060057158 - Buchholz; Ursula ;   et al.
2006-03-16
Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes
App 20060024797 - Krempl; Christine D. ;   et al.
2006-02-02
Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes
App 20060018927 - Krempl; Christine D. ;   et al.
2006-01-26
Production of attenuated negative stranded RNA virus vaccines from cloned nucleotide sequences
App 20050287540 - Murphy, Brian R. ;   et al.
2005-12-29
Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules
App 20050220767 - Collins, Peter L. ;   et al.
2005-10-06
Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes
Grant 6,923,971 - Krempl , et al. August 2, 2
2005-08-02
Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules
App 20050147622 - Collins, Peter L. ;   et al.
2005-07-07
Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences
App 20050100557 - Collins, Peter L. ;   et al.
2005-05-12
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus
App 20050100886 - Pletnev, Alexander G. ;   et al.
2005-05-12
Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
App 20050010043 - Whitehead, Stephen S. ;   et al.
2005-01-13
Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes
App 20040258714 - Krempl, Christine D. ;   et al.
2004-12-23
Recombinant human metapneumovirus and its use
App 20040241188 - Collins, Peter L. ;   et al.
2004-12-02
Human neutralizing monoclonal antibodies to respiratory syncytial virus
App 20040234528 - Burton, Dennis R. ;   et al.
2004-11-25
Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from cDNA and use of recombinant HPIV2 in immonogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens
App 20040204581 - Skiadopoulos, Mario H. ;   et al.
2004-10-14
Recovery of recombinant human parainfluenza virus type 1 (HPIV1) from cDNA and use of recombinant HPIV1 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens
App 20040142448 - Murphy, Brian R. ;   et al.
2004-07-22
Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2
Grant 6,713,066 - Collins , et al. March 30, 2
2004-03-30
Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences
Grant 6,689,367 - Collins , et al. February 10, 2
2004-02-10
Human neutralizing monoclonal antibodies to respiratory syncytial virus
Grant 6,685,942 - Burton , et al. February 3, 2
2004-02-03
Respiratory syncytial virus vaccines expressing protective antigens from promotor- proximal genes
App 20040005542 - Krempl, Christine D ;   et al.
2004-01-08
Neutralizing monoclonal antibodies to respiratory syncytial virus
App 20040005324 - Pilkington, Glenn R. ;   et al.
2004-01-08
Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
App 20030082209 - Skiadopoulos, Mario H. ;   et al.
2003-05-01
Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens
App 20020155581 - Murphy, Brian R. ;   et al.
2002-10-24
Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes
App 20020146433 - Krempl, Christine D. ;   et al.
2002-10-10
Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essential gene
Grant 6,410,023 - Durbin , et al. June 25, 2
2002-06-25
Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
Grant 5,993,824 - Murphy , et al. November 30, 1
1999-11-30
Attenuated respiratory syncytial virus vaccine compositions
Grant 5,922,326 - Murphy , et al. July 13, 1
1999-07-13
Attenuated respiratory syncytial virus vaccine compositions
Grant 5,882,651 - Murphy , et al. March 16, 1
1999-03-16
Human neutralizing monoclonal antibodies to respiratory syncytial virus
Grant 5,762,905 - Burton , et al. June 9, 1
1998-06-09
Human use of avian-human reassortants as vaccines for influenza A virus
Grant 4,552,758 - Murphy , et al. November 12, 1
1985-11-12
Temperature-sensitive recombinant mutant viruses and a process for producing same
Grant 3,992,522 - Chanock , et al. November 16, 1
1976-11-16
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed